New and Emerging Treatments for Cystic Fibrosis Peter J. BarryAndrew M. Jones Leading Article 20 June 2015 Pages: 1165 - 1175
Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (MGD) Adam R. ThodeRobert A. Latkany Leading Article 01 July 2015 Pages: 1177 - 1185
Current Treatment of Dyslipidemia: A New Paradigm for Statin Drug Use and the Need for Additional Therapies Richard KonesUmme Rumana Review Article 27 June 2015 Pages: 1187 - 1199
Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs Richard KonesUmme Rumana Review Article 14 July 2015 Pages: 1201 - 1228
Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future Giuseppe De LucaStefano SavonittoHarry Suryapranata Review Article 16 July 2015 Pages: 1229 - 1253
Acamprosate: A Review of Its Use in Alcohol Dependence Greg L. Plosker Adis Drug Evaluation 18 June 2015 Pages: 1255 - 1268
Naltrexone ER/Bupropion ER: A Review in Obesity Management Sarah L. GreigGillian M. Keating Adis Drug Evaluation 24 June 2015 Pages: 1269 - 1280
Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections Lesley J. Scott Adis Drug Evaluation 24 June 2015 Pages: 1281 - 1291
Recombinant Human Parathyroid Hormone (1–84): A Review in Hypoparathyroidism Esther S. KimGillian M. Keating Adis Drug Evaluation 16 July 2015 Pages: 1293 - 1303
Eluxadoline: First Global Approval Karly P. Garnock-Jones AdisInsight Report 07 July 2015 Pages: 1305 - 1310